Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07459621 · ClinicalTrials.gov registry record · NA
Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking
A NA study, sponsored by Kaiser Permanente.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
NCT07459621: Recruiting NA study, sponsored by Kaiser Permanente.
NCT07459621 is a NA study that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 800 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07459621, a NA study, is actively recruiting participants, sponsored by Kaiser Permanente.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
Study Summary
The goal of this study is to compare the effectiveness of two smoking cessation programs to determine which better helps people change their smoking behavior, the control or the experimental intervention? Both interventions include access to a mHealth app and other publicly available stop-smoking resources. The two app versions each include best practice advice and guidance for quitting smoking, but one includes additional content designed for people who aren't ready to quit smoking. The investigators hypothesize that people who receive the experimental intervention will be more likely to request additional stop-smoking resources offered through the intervention and report smoking abstinence after 6 months. The investigators also hypothesize people assigned to the experimental app will have better app engagement and be more likely to report positive changes in their smoking behavior and use of other evidence-based stop smoking treatments that are publicly available.
Primary Outcome
Composite indicator of (1) Earning the ability to request free nicotine replacement therapy (NRT) through sufficient app participation and requesting NRT and/or (2) accessing free quitline services through the app.
Interventions
- BEHAVIORAL Control Intervention
- BEHAVIORAL Experimental Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2026-04-07 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT07459621 shows while recruiting
NCT07459621 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Intervention is the first listed.
NCT07459621 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07459621 about?
NCT07459621 is a clinical study titled "Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking". The goal of this study is to compare the effectiveness of two smoking cessation programs to determine which better helps people change their smoking behavior, the control or the experimental intervention? Both interventions include access to a mHealth app and other publicly available stop-smoking re...
What is the current status of trial NCT07459621?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2026-04-07. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT07459621?
The interventions under investigation include: Control Intervention (BEHAVIORAL), Experimental Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07459621?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07459621's enrollment target sits among peer trials
800 135th of 2000 higher than 1,861 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI